Resmed
Open
$212.00
Prev. Close
$211.76
High
$212.52
Low
$211.97
Market Snapshot
$30.93B
20.8
8.49
$4.93B
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
ResMed's stock fell 2.4%, reflecting a market value of $31.5 billion, despite annual revenue of $5.4 billion in the sleep apnea and respiratory care industry.
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Recently from Cashu
ResMed Strengthens Sleep Apnea Solutions with Innovative Technology and Telehealth Advancements
ResMed Expands Its Presence in the Sleep Apnea Market with Innovative Solutions ResMed, a leader in cloud-connected devices and solutions for sleep apnea and chronic obstructive pulmonary disease (COP…
ResMed Innovates in Patient Care Solutions Amid Healthcare Industry Challenges
ResMed Leverages Innovation to Enhance Patient Care Amid Industry Challenges ResMed, a leader in cloud-connected devices for people with sleep apnea and chronic obstructive pulmonary disease (COPD), c…
ResMed Expands Innovations in Sleep Apnea Treatment and Digital Health Solutions
ResMed Reinforces Commitment to Expansion in Sleep Apnea Market Amid shifting market landscapes and consumer health demands, ResMed focuses on expanding its innovative solutions for sleep apnea treatm…
ResMed Innovates in Healthcare Technology Amid Market Volatility and Tech Sector Challenges
ResMed's Focus on Innovation Amidst Market Volatility As major tech companies prepare for their earnings reports, ResMed stands out in the healthcare technology sector, focusing on innovation in sleep…